Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The PREVENT Resilience Study

NCT: NCT07568145 · NOT_YET_RECRUITING

NCT IDNCT07568145
StatusNOT_YET_RECRUITING
Start Date2026-05
Completion2028-03

Brief Summary

PTSD is one of the most universal and severe psychiatric disorders whose incidence continues to rise due to the common exposure to severe trauma in the United States and worldwide. After trauma, a proportion of individuals maintains high symptoms of PTSD and depression, which can persist for years. The early weeks following trauma present a unique opportunity to deliver early interventions that can prevent chronic PTSD and depression from occurring, and the researchers propose a brain-based intervention that will reduce reactivity to threat, an early risk mechanism for chronic PTSD. This study is being done to learn more about whether brain stimulation in the weeks after a trauma can change brain activity that is linked to Post-Traumatic Stress Disorder (PTSD).

Frequently Asked Questions

What is The PREVENT Resilience Study?

The PREVENT Resilience Study is a clinical trial registered under NCT07568145. Current status: NOT_YET_RECRUITING.

What is the status of NCT07568145?

The current status of NCT07568145 (The PREVENT Resilience Study) is: NOT_YET_RECRUITING.

When did The PREVENT Resilience Study start?

The PREVENT Resilience Study started on 2026-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.